Austria Manuel Reiberg, president of the Forum of the Research-Based Pharmaceutical Industry in Austria (FOPI), which represents the 27 leading pharmaceutical innovators in Austria focused on pharmaceutical innovation, discusses the struggles facing drug innovation under the new reimbursement system, as well as the steps that must be taken to bolster the…
Could you give our readers a snapshot of the association and its role in the Austrian pharmaceutical context? FOPI is a small and specialized industry association that has a homogenous membership structure. This structure is based on regulations in its statutes and our understanding of being a purely R&D Pharma…
See our Cookie Privacy Policy Here